EdgarLookup

Entera Bio Ltd. — Quarterly Financials

Quarterly figures from SEC EDGAR XBRL filings (10-Q)

These figures are extracted from XBRL-tagged quarterly reports (10-Q) that Entera Bio Ltd. filed with the SEC. Values are as reported for each individual quarter (Q1, Q2, Q3, Q4) — not cumulative year-to-date. Negative figures indicate a loss.

Overview All Filings Annual Quarterly Insiders

Revenue — By Quarter

Quarter Fiscal Year Period End Value Filed
Q3 2025 Sep 30, 2025 $0 Nov 14, 2025
Q2 2025 Jun 30, 2025 $0 Aug 8, 2025
Q1 2025 Mar 31, 2025 $42.0K May 9, 2025
Q3 2025 Sep 30, 2024 $42.0K Nov 14, 2025
Q2 2025 Jun 30, 2024 $57.0K Aug 8, 2025
Q1 2025 Mar 31, 2024 $0 May 9, 2025
Q3 2024 Sep 30, 2023 $0 Nov 8, 2024
Q2 2024 Jun 30, 2023 $0 Aug 9, 2024
Q1 2023 Mar 31, 2023 $0 May 5, 2023
Q3 2023 Sep 30, 2022 $8.0K Nov 14, 2023
Q2 2023 Jun 30, 2022 $44.0K Aug 11, 2023
Q1 2023 Mar 31, 2022 $68.0K May 5, 2023
Q3 2022 Sep 30, 2021 $140.0K Nov 10, 2022
Q2 2022 Jun 30, 2021 $109.0K Aug 11, 2022
Q1 2022 Mar 31, 2021 $157.0K May 12, 2022

Net Income — By Quarter

Quarter Fiscal Year Period End Value Filed
Q3 2025 Sep 30, 2025 ($3.20M) Nov 14, 2025
Q2 2025 Jun 30, 2025 ($2.66M) Aug 8, 2025
Q1 2025 Mar 31, 2025 ($2.57M) May 9, 2025
Q3 2025 Sep 30, 2024 ($3.02M) Nov 14, 2025
Q2 2025 Jun 30, 2024 ($2.15M) Aug 8, 2025
Q1 2025 Mar 31, 2024 ($2.02M) May 9, 2025
Q3 2024 Sep 30, 2023 ($2.38M) Nov 8, 2024
Q2 2024 Jun 30, 2023 ($2.33M) Aug 9, 2024
Q1 2024 Mar 31, 2023 ($2.19M) May 10, 2024
Q3 2023 Sep 30, 2022 ($3.07M) Nov 14, 2023
Q2 2023 Jun 30, 2022 ($3.19M) Aug 11, 2023
Q1 2023 Mar 31, 2022 ($3.78M) May 5, 2023
Q3 2022 Sep 30, 2021 ($3.21M) Nov 10, 2022
Q2 2022 Jun 30, 2021 ($2.58M) Aug 11, 2022
Q1 2022 Mar 31, 2021 ($2.30M) May 12, 2022

Operating Income — By Quarter

Quarter Fiscal Year Period End Value Filed
Q3 2025 Sep 30, 2025 ($3.26M) Nov 14, 2025
Q2 2025 Jun 30, 2025 ($2.67M) Aug 8, 2025
Q1 2025 Mar 31, 2025 ($2.56M) May 9, 2025
Q3 2025 Sep 30, 2024 ($3.02M) Nov 14, 2025
Q2 2025 Jun 30, 2024 ($2.17M) Aug 8, 2025
Q1 2025 Mar 31, 2024 ($2.06M) May 9, 2025
Q3 2024 Sep 30, 2023 ($2.39M) Nov 8, 2024
Q2 2024 Jun 30, 2023 ($2.33M) Aug 9, 2024
Q1 2024 Mar 31, 2023 ($2.21M) May 10, 2024
Q3 2023 Sep 30, 2022 ($2.87M) Nov 14, 2023
Q2 2023 Jun 30, 2022 ($3.25M) Aug 11, 2023
Q1 2023 Mar 31, 2022 ($3.84M) May 5, 2023
Q3 2022 Sep 30, 2021 ($3.22M) Nov 10, 2022
Q2 2022 Jun 30, 2021 ($2.57M) Aug 11, 2022
Q1 2022 Mar 31, 2021 ($2.34M) May 12, 2022